This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 9, No 10 (2020): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19189, first published .
The Effect of Multi-Parametric Magnetic Resonance Imaging in Standard of Care for Nonalcoholic Fatty Liver Disease: Protocol for a Randomized Control Trial

The Effect of Multi-Parametric Magnetic Resonance Imaging in Standard of Care for Nonalcoholic Fatty Liver Disease: Protocol for a Randomized Control Trial

The Effect of Multi-Parametric Magnetic Resonance Imaging in Standard of Care for Nonalcoholic Fatty Liver Disease: Protocol for a Randomized Control Trial

Authors of this article:

Dimitar Tonev1 Author Orcid Image ;   Elizabeth Shumbayawonda1 Author Orcid Image ;   Louise Ann Tetlow1 Author Orcid Image ;   Laura Herdman1 Author Orcid Image ;   Marika French1 Author Orcid Image ;   Soubera Rymell1 Author Orcid Image ;   Helena Thomaides-Brears1 Author Orcid Image ;   Filipe Caseiro-Alves2 Author Orcid Image ;   Miguel Castelo-Branco2 Author Orcid Image ;   Carlos Ferreira1 Author Orcid Image ;   Minneke Coenraad3 Author Orcid Image ;   Hildo Lamb3 Author Orcid Image ;   Meinrad Beer4 Author Orcid Image ;   Matt Kelly1 Author Orcid Image ;   Rajarshi Banerjee1 Author Orcid Image ;   Matthias Dollinger4 Author Orcid Image ;   RADIcAL11, 5
Article Authors Cited by (5) Tweetations (1) Metrics

Journals

  1. Schaapman J, Coenraad M, Lamb H. Response to letter: Multiparametric magnetic resonance imaging in patients with nonalcoholic fatty liver disease. Journal of Magnetic Resonance Imaging 2021;53(6):1941 View
  2. Herrmann C, Els A, Boehmert L, Periquito J, Eigentler T, Millward J, Waiczies S, Kuchling J, Paul F, Niendorf T. Simultaneous T2 and mapping of multiple sclerosis lesions with radial RARE‐EPI. Magnetic Resonance in Medicine 2021;86(3):1383 View
  3. Andersson A, Kelly M, Imajo K, Nakajima A, Fallowfield J, Hirschfield G, Pavlides M, Sanyal A, Noureddin M, Banerjee R, Dennis A, Harrison S. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clinical Gastroenterology and Hepatology 2022;20(11):2451 View
  4. Bresnahan R, Duarte R, Mahon J, Beale S, Chaplin M, Bhattacharyya D, Houten R, Edwards K, Nevitt S, Maden M, Boland A. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation. Health Technology Assessment 2023:1 View
  5. Simon T, Wilechansky R, Stoyanova S, Grossman A, Dichtel L, Lauer G, Miller K, Hoshida Y, Corey K, Loomba R, Chung R, Chan A. Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis. JAMA 2024;331(11):920 View